Paracrine mechanisms of mesenchymal stem cells in tissue repair

Methods in Molecular Biology

Volumn 1416, Issue , 2016, Pages 123-146

  Gnecchi, Massimiliano ^a,b,c   Danieli, Patrizia ^a,b   Malpasso, Giuseppe ^a,b   Ciuffreda, Maria Chiara ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Angiogenesis; Cell therapy; Conditioned medium; Cytoprotection; Mesenchymal stem cells; Paracrine mechanisms; Rigenerative medicine; Soluble factors; Tissue regeneration; Tissue repair

Indexed keywords

CELL PROTECTION; EXOSOME; HUMAN; INFLAMMATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOLECULAR THERAPY; NONHUMAN; PARACRINE SIGNALING; PROTEIN SECRETION; TISSUE REPAIR; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; MESENCHYMAL STROMA CELL; PROCEDURES; TISSUE REGENERATION;

ANIMALS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GUIDED TISSUE REGENERATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PARACRINE COMMUNICATION;

EID: 84990180635     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3584-0_7     Document Type: Chapter

References (181)

1. Tomita S, Li RK, Weisel RD et al (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-II256
2. Morigi M, Imberti B, Zoja C et al (2004) Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794-1804
3. Pittenger MF, Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20
4. Morigi M, Introna M, Imberti B et al (2008) Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26:2075-2082
5. Morigi M, De Coppi P (2014) Cell therapy for kidney injury: different options and mechanisms— mesenchymal and amniotic fluid stem cells. Nephron Exp Nephrol 126:59
6. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736
7. Wakabayashi K, Nagai A, Sheikh AM et al (2010) Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 88:1017-1025
8. Jung KH, Shin HP, Lee S et al (2009) Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int 29:898-909
9. Kinnaird T, Stabile E, Burnett MS et al (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549
10. Makino S, Fukuda K, Miyoshi S et al (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103:697-705
11. Martin-Rendon E, Sweeney D, Lu F et al (2008) 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang 95:137-148
12. Pisano F, Altomare C, Cervio E et al (2015) Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation. Stem Cells 33:1187-1199
13. Rangappa S, Entwistle JW, Wechsler AS et al (2003) Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 126:124-132
14. Xu M, Wani M, Dai YS et al (2004) Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation 110:2658-2665
15. Hatzistergos KE, Quevedo H, Oskouei BN et al (2010) Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107:913-922
16. Loffredo FS, Steinhauser ML, Gannon J et al (2011) Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8:389-398
17. Noiseux N, Gnecchi M, Lopez-Ilasaca M et al (2006) Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14:840-850
18. Duffield JS, Park KM, Hsiao LL et al (2005) Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755
19. Lange C, Togel F, Ittrich H et al (2005) Administered mesenchymal stem cells enhance recovery from ischemia/reperfusioninduced acute renal failure in rats. Kidney Int 68:1613-1617
20. Togel F, Hu Z, Weiss K et al (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31-F42
21. Togel F, Weiss K, Yang Y et al (2007) Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292:F1626-F1635
22. Chen J, Li Y, Wang L et al (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-1011
23. Wu Y, Chen L, Scott PG et al (2007) Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25:2648-2659
24. Sasaki M, Abe R, Fujita Y et al (2008) Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180:2581-2587
25. Li H, Fu X, Ouyang Y et al (2006) Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res 326:725-736
26. Javazon EH, Keswani SG, Badillo AT et al (2007) Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair Regen 15:350-359
27. Williams AR, Hare JM (2011) Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109:923-940
28. Iso Y, Spees JL, Serrano C et al (2007) Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354: 700-706
29. Terrovitis JV, Smith RR, Marban E (2010) Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 106:479-494
30. Rodrigues M, Griffith LG, Wells A (2010) Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 1:32
31. Song H, Cha MJ, Song BW et al (2010) Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 28:555-563
32. Muller-Ehmsen J, Krausgrill B, Burst V et al (2006) Effective engraftment but poor midterm persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 41:876-884
33. Rehman J, Traktuev D, Li J et al (2004) Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292-1298
34. Moon MH, Kim SY, Kim YJ et al (2006) Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem 17:279-290
35. Imberti B, Morigi M, Tomasoni S et al (2007) Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18:2921-2928
36. Horita Y, Honmou O, Harada K et al (2006) Intravenous administration of glial cell linederived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84:1495-1504
37. Kang SK, Lee DH, Bae YC et al (2003) Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 183:355-366
38. Mora-Lee S, Sirerol-Piquer MS, Gutierrez-Perez M et al (2012) Therapeutic effects of hMAPC and hMSC transplantation after stroke in mice. PLoS One 7, e43683
39. Chopp M, Li Y (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol 1:92-100
40. Gnecchi M, He H, Liang OD et al (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368
41. Gnecchi M, He H, Noiseux N et al (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cellmediated cardiac protection and functional improvement. FASEB J 20:661-669
42. Du T, Cheng J, Zhong L et al (2012) The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemiareperfusion injury via an endocrine mechanism. Cytotherapy 14:1215-1227
43. Fang TC, Pang CY, Chiu SC et al (2012) Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PLoS One 7, e46504
44. Bi B, Schmitt R, Israilova M et al (2007) Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-2496
45. Kanki S, Segers VF, Wu W et al (2011) Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium. Circ Heart Fail 4:509-518
46. Timmers L, Lim SK, Hoefer IE et al (2011) Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6:206-214
47. Beohar N, Rapp J, Pandya S et al (2010) Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J Am Coll Cardiol 56:1287-1297
48. Aejaz HM, Aleem AK, Parveen N et al (2007) Stem cell therapy-present status. Transplant Proc 39:694-699
49. Daley GQ, Scadden DT (2008) Prospects for stem cell-based therapy. Cell 132:544-548
50. Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441:1094-1096
51. Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23: 845-856
52. Little MH (2006) Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17:2390-2401
53. Cantley LG (2005) Adult stem cells in the repair of the injured renal tubule. Nat Clin Pract Nephrol 1:22-32
54. Morigi M, Benigni A, Remuzzi G et al (2006) The regenerative potential of stem cells in acute renal failure. Cell Transplant 15(Suppl 1):S111-S117
55. Lim BK, Choi JH, Nam JH et al (2006) Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc Res 71:517-526
56. Takahashi M, Li TS, Suzuki R et al (2006) Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol Heart Circ Physiol 291:H886-H893
57. Uemura R, Xu M, Ahmad N et al (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98:1414-1421
58. Xu M, Uemura R, Dai Y et al (2007) In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 42:441-448
59. Danieli P, Malpasso G, Ciuffreda MC et al (2015) Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis. Stem Cells Transl Med 4:448-458
60. Halabian R, Roudkenar MH, Jahanian-Najafabadi A et al (2015) Co-culture of bone marrow-derived mesenchymal stem cells overexpressing lipocalin 2 with HK-2 and HEK293 cells protects the kidney cells against cisplatin-induced injury. Cell Biol Int 39:152-163
61. Drago D, Cossetti C, Iraci N et al (2013) The stem cell secretome and its role in brain repair. Biochimie 95:2271-2285
62. Chen J, Li Y, Katakowski M et al (2003) Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778-786
63. Egashira Y, Sugitani S, Suzuki Y et al (2012) The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res 1461:87-95
64. Wei X, Du Z, Zhao L et al (2009) IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells 27:478-488
65. Kinnaird T, Stabile E, Burnett MS et al (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685
66. Ohnishi S, Yasuda T, Kitamura S et al (2007) Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells 25: 1166-1177
67. Jiang S, Haider HK, Idris NM et al (2006) Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 99:776-784
68. Nagaya N, Fujii T, Iwase T et al (2004) Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287:H2670-H2676
69. Tomita S, Mickle DA, Weisel RD et al (2002) Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123:1132-1140
70. McFarlin K, Gao X, Liu YB et al (2006) Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen 14:471-478
71. Alfaro MP, Pagni M, Vincent A et al (2008) The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proc Natl Acad Sci U S A 105:18366-18371
72. Chen L, Tredget EE, Wu PY et al (2008) Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 3, e1886
73. Wang Y, Lian F, Li J et al (2012) Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats. J Transl Med 10:133
74. English K (2013) Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol 91:19-26
75. Klinker MW, Wei CH (2015) Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells 7:556-567
76. Iyer SS, Rojas M (2008) Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin Biol Ther 8:569-581
77. Zhu XY, Lerman A, Lerman LO (2013) Concise review: mesenchymal stem cell treatment for ischemic kidney disease. Stem Cells 31:1731-1736
78. Gnecchi M, Danieli P, Cervio E (2012) Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 57:48-55
79. Puglisi MA, Tesori V, Lattanzi W et al (2011) Therapeutic implications of mesenchymal stem cells in liver injury. J Biomed Biotechnol 2011:860578
80. Eliopoulos N, Zhao J, Bouchentouf M et al (2010) Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. Am J Physiol Renal Physiol 299:F1288-F1298
81. Ramesh G, Reeves WB (2002) TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110:835-842
82. Zhang B, Ramesh G, Norbury CC et al (2007) Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int 72:37-44
83. Morigi M, Rota C, Montemurro T et al (2010) Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 28:513-522
84. Yagi H, Soto-Gutierrez A, Navarro-Alvarez N et al (2010) Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18:1857-1864
85. Duffy MM, Ritter T, Ceredig R et al (2011) Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2:34
86. Franquesa M, Hoogduijn MJ, Bestard O et al (2012) Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol 3:212
87. Raffaghello L, Bianchi G, Bertolotto M et al (2008) Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 26:151-162
88. Spaggiari GM, Capobianco A, Abdelrazik H et al (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327-1333
89. Corridoni D, Arseneau KO, Cominelli F (2014) Inflammatory bowel disease. Immunol Lett 161:231-235
90. Gonzalez MA, Gonzalez-Rey E, Rico L et al (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978-989
91. Zhang Q, Shi S, Liu Y et al (2009) Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 183:7787-7798
92. Zhao Y, Wang L, Jin Y et al (2012) Fas ligand regulates the immunomodulatory properties of dental pulp stem cells. J Dent Res 91:948-954
93. Akiyama K, Chen C, Wang D et al (2012) Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 10:544-555
94. Ohnishi S, Yanagawa B, Tanaka K et al (2007) Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol 42:88-97
95. Van Linthout S, Savvatis K, Miteva K et al (2011) Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J 32:2168-2178
96. Fuse K, Kodama M, Hanawa H et al (2001) Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin Exp Immunol 124:346-352
97. Yang CC, Shih YH, Ko MH et al (2008) Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS One 3, e3336
98. Gerdoni E, Gallo B, Casazza S et al (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 61:219-227
99. Zappia E, Casazza S, Pedemonte E et al (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761
100. McCoy MK, Martinez TN, Ruhn KA et al (2008) Autologous transplants of adiposederived adult stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson’s disease. Exp Neurol 210:14-29
101. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822
102. Francois M, Romieu-Mourez R, Li M et al (2012) Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20:187-195
103. Prockop DJ, Oh JY (2012) Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 20:14-20
104. Karantalis V, Hare JM (2015) Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res 116:1413-1430
105. Nakanishi C, Yamagishi M, Yamahara K et al (2008) Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun 374:11-16
106. Linke A, Muller P, Nurzynska D et al (2005) Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 102:8966-8971
107. Amado LC, Saliaris AP, Schuleri KH et al (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474-11479
108. Galindo LT, Filippo TR, Semedo P et al (2011) Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int 2011:564089
109. Rivera FJ, Kandasamy M, Couillard-Despres S et al (2008) Oligodendrogenesis of adult neural progenitors: differential effects of ciliary neurotrophic factor and mesenchymal stem cell derived factors. J Neurochem 107:832-843
110. Constantin G, Marconi S, Rossi B et al (2009) Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27:2624–2635
111. Zhang J, Li Y, Chen J et al (2005) Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 195:16-26
112. Zhang J, Li Y, Lu M et al (2006) Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 84:587-595
113. Bai L, Lennon DP, Caplan AI et al (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15:862-870
114. Voulgari-Kokota A, Fairless R, Karamita M et al (2012) Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function. Exp Neurol 236:161-170
115. Kim WS, Park BS, Sung JH et al (2007) Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 48:15-24
116. Lee EY, Xia Y, Kim WS et al (2009) Hypoxiaenhanced wound-healing function of adiposederived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen 17:540-547
117. Smith AN, Willis E, Chan VT et al (2010) Mesenchymal stem cells induce dermal fibroblast responses to injury. Exp Cell Res 316:48-54
118. Nagaya N, Kangawa K, Itoh T et al (2005) Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112: 1128-1135
119. Oyagi S, Hirose M, Kojima M et al (2006) Therapeutic effect of transplanting HGFtreated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 44:742-748
120. Ninichuk V, Gross O, Segerer S et al (2006) Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 70:121-129
121. Ortiz LA, Gambelli F, McBride C et al (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100:8407-8411
122. Gnecchi M, Zhang Z, Ni A et al (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219
123. Berry MF, Engler AJ, Woo YJ et al (2006) Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290:H2196-H2203
124. Xu X, Xu Z, Xu Y et al (2005) Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis 16:245-255
125. Ohnishi S, Sumiyoshi H, Kitamura S et al (2007) Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett 581:3961-3966
126. Nasir GA, Mohsin S, Khan M et al (2013) Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med 11:78,5876-11-78
127. Li Q, Zhou X, Shi Y et al (2013) In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS One 8, e62363
128. Chang YJ, Liu JW, Lin PC et al (2009) Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci 85:517-725
129. Rabani V, Shahsavani M, Gharavi M et al (2010) Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol Int 34:601-605
130. Zhao DC, Lei JX, Chen R et al (2005) Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 11:3431-3440
131. Abdel Aziz MT, Atta HM, Mahfouz S et al (2007) Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 40:893-899
132. Tanimoto H, Terai S, Taro T et al (2013) Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow. Cell Tissue Res 354:717-728
133. Friedman SL (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88:125-172
134. Parekkadan B, van Poll D, Megeed Z et al (2007) Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 363: 247-252
135. Toonkel RL, Hare JM, Matthay MA et al (2013) Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. Am J Respir Crit Care Med 188:133-140
136. Rojas M, Xu J, Woods CR et al (2005) Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145-152
137. Ortiz LA, Dutreil M, Fattman C et al (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104:11002-11007
138. Aguilar S, Scotton CJ, McNulty K et al (2009) Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One 4, e8013
139. Epperly MW, Guo H, Gretton JE et al (2003) Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 29:213-224
140. Hashimoto N, Jin H, Liu T et al (2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113:243-252
141. Phillips RJ, Burdick MD, Hong K et al (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114:438-446
142. Feygin J, Mansoor A, Eckman P et al (2007) Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation. Am J Physiol Heart Circ Physiol 293: H1772-H1780
143. Gnecchi M, He H, Melo LG et al (2009) Early beneficial effects of bone marrowderived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 27: 971-979
144. Yoon YS, Wecker A, Heyd L et al (2005) Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115:326-338
145. Mirotsou M, Zhang Z, Deb A et al (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A 104:1643-1648
146. Lee RH, Pulin AA, Seo MJ et al (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63
147. Parekkadan B, van Poll D, Suganuma K et al (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2, e941
148. Nguyen BK, Maltais S, Perrault LP et al (2010) Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J Cardiovasc Transl Res 3:547-558
149. Park CW, Kim KS, Bae S et al (2009) Cytokine secretion profiling of human mesenchymal stem cells by antibody array. Int J Stem Cells 2:59-68
150. Skalnikova H, Motlik J, Gadher SJ et al (2011) Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 11:691-708
151. Ranganath SH, Levy O, Inamdar MS et al (2012) Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10:244-258
152. Choi YA, Lim J, Kim KM et al (2010) Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J Proteome Res 9:2946-2956
153. Estrada R, Li N, Sarojini H et al (2009) Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol 219:563-571
154. Kim JM, Kim J, Kim YH et al (2013) Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis. J Cell Physiol 228:216-224
155. Li N, Sarojini H, An J et al (2010) Prosaposin in the secretome of marrow stroma-derived neural progenitor cells protects neural cells from apoptotic death. J Neurochem 112:1527-1538
156. Liu CH, Hwang SM (2005) Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32:270-279
157. Sarojini H, Estrada R, Lu H et al (2008) PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts. J Cell Biochem 104:1793-1802
158. Tasso R, Gaetani M, Molino E et al (2012) The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials 33:2086-2096
159. Lee MJ, Kim J, Kim MY et al (2010) Proteomic analysis of tumor necrosis factoralpha-induced secretome of human adipose tissue-derived mesenchymal stem cells. J Proteome Res 9:1754-1762
160. Sze SK, de Kleijn DP, Lai RC et al (2007) Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Mol Cell Proteomics 6: 1680-1689
161. Cervio E, Barile L, Moccetti T et al (2015) Exosomes for intramyocardial intercellular communication. Stem Cells Int 2015:482171
162. Li T, Yan Y, Wang B et al (2013) Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 22:845-854
163. Tan CY, Lai RC, Wong W et al (2014) Mesenchymal stem cell-derived exosomes promote hepatic regeneration in druginduced liver injury models. Stem Cell Res Ther 5:76
164. Lee C, Mitsialis SA, Aslam M et al (2012) Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxiainduced pulmonary hypertension. Circulation 126:2601-2611
165. Sdrimas K, Kourembanas S (2014) MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy. Antioxid Redox Signal 21:1905-1915
166. Zhu YG, Feng XM, Abbott J et al (2014) Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxininduced acute lung injury in mice. Stem Cells 32:116-125
167. Gatti S, Bruno S, Deregibus MC et al (2011) Microvesicles derived from human adult mesenchymal stem cells protect against ischaemiareperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26: 1474-1483
168. Reis LA, Borges FT, Simoes MJ et al (2012) Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicininduced acute kidney injury through paracrine effects in rats. PLoS One 7, e44092
169. Tomasoni S, Longaretti L, Rota C et al (2013) Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22:772-780
170. Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214-222
171. Martinez MC, Andriantsitohaina R (2011) Microparticles in angiogenesis: therapeutic potential. Circ Res 109:110-119
172. Janowska-Wieczorek A, Wysoczynski M, Kijowski J et al (2005) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:752-760
173. Ratajczak J, Wysoczynski M, Hayek F et al (2006) Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20: 1487-1495
174. Bruno S, Grange C, Deregibus MC et al (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067
175. Collino F, Deregibus MC, Bruno S et al (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5, e11803
176. Zhang Y, Chopp M, Meng Y et al (2015) Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg 122:856-867
177. EL Andaloussi S, Mager I, Breakefield XO et al (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347-357
178. Lai RC, Yeo RW, Tan KH et al (2013) Exosomes for drug delivery-a novel application for the mesenchymal stem cell. Biotechnol Adv 31:543-551
179. Malik DK, Baboota S, Ahuja A et al (2007) Recent advances in protein and peptide drug delivery systems. Curr Drug Deliv 4:141-151
180. Zhang G, Nakamura Y, Wang X et al (2007) Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit + cell homing to the infarcted heart. Tissue Eng 13: 2063-2071
181. Segers VF, Tokunou T, Higgins LJ et al (2007) Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 116:1683-1692